Centralus Health is now providing a new, non-invasive treatment option for prostate cancer patients in the Ithaca region. The individualized approach aims to target and destroy cancerous tissue without the side effects often associated with customary surgery or radiation.
The treatment, utilizing focused ultrasound, offers a perhaps life-changing choice for men diagnosed with localized prostate cancer.Centralus Health specialists tailor the therapy to each patient’s specific anatomy and tumor characteristics, minimizing damage to surrounding healthy tissue. This advancement addresses a critical need for less invasive cancer treatments and improved quality of life for patients.
Centralus Health’s program focuses on High-Intensity Focused Ultrasound (HIFU),a technique that uses sound waves to precisely heat and destroy prostate cancer cells. Unlike radical prostatectomy or radiation therapy, HIFU is an outpatient procedure with a significantly shorter recovery time. Patients typically experience minimal pain,urinary incontinence,and sexual dysfunction.
“We are committed to bringing the latest advancements in cancer care to our community,” said a Centralus Health representative. “This non-invasive treatment option provides men with prostate cancer a chance to fight the disease with fewer side effects and a quicker return to their normal lives.”
Prostate cancer is the most common cancer in American men, with approximately one in eight men receiving a diagnosis during their lifetime, according to the American Cancer Society. Early detection and innovative treatment options like those offered by Centralus Health are crucial in improving patient outcomes. Individuals concerned about prostate cancer are encouraged to consult with their healthcare provider for screening and personalized treatment plans.
